164 related articles for article (PubMed ID: 7876896)
1. Rational design of hirulog-type inhibitors of thrombin.
Egner U; Hoyer GA; Schleuning WD
J Comput Aided Mol Des; 1994 Oct; 8(5):479-90. PubMed ID: 7876896
[TBL] [Abstract][Full Text] [Related]
2. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
Bode W; Turk D; Stürzebecher J
Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
[TBL] [Abstract][Full Text] [Related]
3. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
Myles T; Le Bonniec BF; Betz A; Stone SR
Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
[TBL] [Abstract][Full Text] [Related]
5. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
6. Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.
Qiu X; Padmanabhan KP; Carperos VE; Tulinsky A; Kline T; Maraganore JM; Fenton JW
Biochemistry; 1992 Dec; 31(47):11689-97. PubMed ID: 1445905
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis.
Yue SY; DiMaio J; Szewczuk Z; Purisima EO; Ni F; Konishi Y
Protein Eng; 1992 Jan; 5(1):77-85. PubMed ID: 1631048
[TBL] [Abstract][Full Text] [Related]
9. Calculation of relative binding free energies and configurational entropies: a structural and thermodynamic analysis of the nature of non-polar binding of thrombin inhibitors based on hirudin55-65.
Wang J; Szewczuk Z; Yue SY; Tsuda Y; Konishi Y; Purisima EO
J Mol Biol; 1995 Oct; 253(3):473-92. PubMed ID: 7473728
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
11. Proton bridging in the interactions of thrombin with hirudin and its mimics.
Kovach IM; Kakalis L; Jordan F; Zhang D
Biochemistry; 2013 Apr; 52(14):2472-81. PubMed ID: 23517305
[TBL] [Abstract][Full Text] [Related]
12. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
Tsuda Y; Cygler M; Gibbs BF; Pedyczak A; Féthière J; Yue SY; Konishi Y
Biochemistry; 1994 Dec; 33(48):14443-51. PubMed ID: 7981204
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
[TBL] [Abstract][Full Text] [Related]
14. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
[TBL] [Abstract][Full Text] [Related]
15. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
16. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
Krishnan R; Mochalkin I; Arni R; Tulinsky A
Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor.
Maraganore JM
Adv Exp Med Biol; 1993; 340():227-36. PubMed ID: 8154339
[No Abstract] [Full Text] [Related]
18. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
[TBL] [Abstract][Full Text] [Related]
20. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
Chang JY
J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]